Home » Resources » Program Briefs » Misoprostol for PPH: Policy Endorsements
Misoprostol for PPH: Policy Endorsements
Several organizations including the WHO, the International Confederation of Midwives & International Federation of Gynecology and Obstetrics, and the United States Pharmacopeia have endorsed misoprostol in its use as an effective uterotonic drug to prevent postpartum hemorrhage (PPH).
Latest News
- UN spotlights life-saving commodities to accelerate MDGs 2012.03.23
- GHS calls for scale-up of miso distribution to reach women who deliver at home 2012.03.19
- Merck for Mothers invites Dr. Ndola Prata to serve on its Advisory Board 2012.02.15
Join Our List
Email:
For Email Marketing you can trust